Stockreport

Raymond James Boosts Monopar Therapeutics (MNPR) PT to $142, Maintains Strong Buy [Yahoo! Finance]

Monopar Therapeutics Inc.  (MNPR) 
PDF price target on Monopar Therapeutics to $142 from $80, while keeping a Strong Buy rating on the shares. The firm thinks that the company's shares can continue to work we [Read more]